CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate.
about
Methamphetamine inhibits antigen processing, presentation, and phagocytosisThe Complex Interaction Between Methamphetamine Abuse and HIV-1 PathogenesisAnimal models for HIV/AIDS researchCan the new humanized mouse model give HIV research a boostShort communication: Methamphetamine treatment increases in vitro and in vivo HIV replication.Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody.Mice transgenic for CD4-specific human CD4, CCR5 and cyclin T1 expression: a new model for investigating HIV-1 transmission and treatment efficacy.Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.Rodent models for HIV-associated neurocognitive disorders.Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory actSummary of presentations at the NIH/NIAID New Humanized Rodent Models 2007 Workshop.Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells.Increased in vivo activation of microglia and astrocytes in the brains of mice transgenic for an infectious R5 human immunodeficiency virus type 1 provirus and for CD4-specific expression of human cyclin T1 in response to stimulation by lipopolysaccHuman immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide.Mouse T-cells restrict replication of human immunodeficiency virus at the level of integration.Murine models for HIV vaccination and challenge.Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating anti-HIV-1 miRNA expression.Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease.Animal models in virus research: their utility and limitations.HIV-1 susceptibility of transgenic rat-derived primary macrophage/T cells and a T cell line that express human receptors, CyclinT1 and CRM1 genes.Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.Synergistic effect of human CycT1 and CRM1 on HIV-1 propagation in rat T cells and macrophages.Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo.
P2860
Q24647304-9662CA60-0020-4B9B-A787-7550A07A3273Q27002500-D7B2FC21-0D4E-4089-93A1-539C5AA6D2ABQ30423656-FFF89008-0850-44C9-8794-79060D509F89Q33315029-7D88A796-BFF5-4B4D-AA4F-D0557ACFACEEQ33686683-3237D517-DFC3-4B59-813A-C7FC39A93544Q33990484-D095A135-4A8F-4794-9BF0-ADD68E00858CQ34730602-AE694A54-E2B8-4766-887F-1441678A717BQ35177355-9292663D-0389-425D-A6CE-ED6CA6DEE408Q35803957-C57F0314-EE90-4BB2-88FF-718C20252C7CQ36229284-EE4746D8-188E-40B9-A34D-A82ECCA60257Q36484055-5BA93C71-4198-4D51-9F73-7383CD9E471BQ36511820-C43E3956-55A4-48F7-BF21-5287332039FDQ36571363-FBE085C6-04C8-424F-933B-A6D53AF4B9C4Q36673268-13A78483-8A97-4473-AE0E-87532A5A4216Q36804543-26286E50-B975-46D3-BE83-6DF43F3092BAQ36916993-8611A421-1782-4267-9963-74744872FD06Q37077665-01E27B31-A440-49B1-9D3B-399EBF430399Q37415416-FD01062C-EF51-4D7F-96C2-CFCCF8B05B20Q37520175-9755C4E1-57B1-4F58-B2CD-B10C96A4ED0AQ38043556-173898AE-667C-4681-A3E1-AFD40A0E3A8FQ38711226-BC42BD3D-3C2F-49FD-AAAE-028170F3895FQ39668496-85576BD9-9026-4CFA-8A78-62588A25A7B2Q39852737-087F0559-282A-470B-B5FA-4ED9D708CE78Q40168499-F12AC5FA-5245-4677-9B89-151AEF988292Q43193366-1A5ECD04-A066-4764-BA76-01D22F92C639
P2860
CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
CD4-specific transgenic expres ...... monocyte-tropic HIV-1 isolate.
@ast
CD4-specific transgenic expres ...... monocyte-tropic HIV-1 isolate.
@en
CD4-specific transgenic expres ...... immunodeficiency virus type 1
@nl
type
label
CD4-specific transgenic expres ...... monocyte-tropic HIV-1 isolate.
@ast
CD4-specific transgenic expres ...... monocyte-tropic HIV-1 isolate.
@en
CD4-specific transgenic expres ...... immunodeficiency virus type 1
@nl
prefLabel
CD4-specific transgenic expres ...... monocyte-tropic HIV-1 isolate.
@ast
CD4-specific transgenic expres ...... monocyte-tropic HIV-1 isolate.
@en
CD4-specific transgenic expres ...... immunodeficiency virus type 1
@nl
P2093
P2860
P1433
P1476
CD4-specific transgenic expres ...... monocyte-tropic HIV-1 isolate.
@en
P2093
Dan R Littman
Harris Goldstein
Jian Hua Zheng
Jinglin Sun
Kristin Osiecki
Laurie Falkin
Timothy Soos
Vineet N Kewalramani
P2860
P304
P356
10.1128/JVI.80.4.1850-1862.2006
P407
P577
2006-02-01T00:00:00Z